Works matching DE "FIDAXOMICIN"

Results: 125

Emergence and Spread of Clostridioides difficile Isolates With Reduced Fidaxomicin Susceptibility in an Acute Care Hospital.

Published in:

Clinical Infectious Diseases, 2025, v. 80, n. 5, p. 984, doi. 10.1093/cid/ciaf028

By:

Redmond, Sarah N;
Cadnum, Jennifer L;
Jencson, Annette L;
Kaple, Claire E;
Wilson, Brigid M;
Skinner, Andrew M;
Gargis, Amy S;
Hwang, Munok;
Choi, Hosoon;
Chatterjee, Piyali;
Jinadatha, Chetan;
Donskey, Curtis J

Publication type:

Article

Real-world comparison of fidaxomicin versus vancomycin or metronidazole in the treatment of Clostridium difficile infection: a systematic review and meta-analysis.

Published in:

European Journal of Clinical Pharmacology, 2022, v. 78, n. 11, p. 1727, doi. 10.1007/s00228-022-03376-1

By:

Dai, Jianfeng;
Gong, Jing;
Guo, Rui

Publication type:

Article

Successful Therapy of Severe Pseudomembranous Clostridium difficile Colitis Using a Combination of Fecal Microbiota Therapy and Fidaxomicin.

Published in:

2017

By:

Konturek, Peter C.;
Haziri, Drilon;
Helfritzsch, Harry;
Hess, Thomas;
Harsch, Igor a.

Publication type:

journal article

Epidemiology, Diagnosis, and Treatment of Clostridioides difficile Infection in Immunocompromised Children.

Published in:

Journal of the Pediatric Infectious Diseases Society, 2021, v. 10, p. S46, doi. 10.1093/jpids/piab078

By:

Cross, Shane J;
Morton, Theodore H;
Wolf, Joshua

Publication type:

Article

Is There a Future for a Tapered-Pulsed Fidaxomicin Regimen for Pediatric Patients With Recurrent Clostridiodes difficile Infections?

Published in:

Journal of the Pediatric Infectious Diseases Society, 2021, v. 10, n. 12, p. 1051, doi. 10.1093/jpids/piab112

By:

Geagan, Nicholas;
Koay, Wei Li Adeline

Publication type:

Article

Antibiotic Therapies for Clostridioides difficile Infection in Children.

Published in:

Journal of the Pediatric Infectious Diseases Society, 2021, v. 10, p. S52, doi. 10.1093/jpids/piab059

By:

Gonzales-Luna, Anne J;
Carlson, Travis J;
Garey, Kevin W

Publication type:

Article

Safety and Pharmacokinetic Study of Fidaxomicin in Children With Clostridium difficile–Associated Diarrhea: A Phase 2a Multicenter Clinical Trial.

Published in:

Journal of the Pediatric Infectious Diseases Society, 2018, v. 7, n. 3, p. 210, doi. 10.1093/jpids/pix037

By:

O'Gorman, Molly A;
Michaels, Marian G;
Kaplan, Sheldon L;
Otley, Anthony;
Kociolek, Larry K;
Hoffenberg, Edward J;
Kim, Kwang Sik;
Nachman, Sharon;
Pfefferkorn, Marian D;
Sentongo, Timothy

Publication type:

Article

Fidaxomicin: A Review of Its Use in Patients with Clostridium difficile Infection.

Published in:

2013

By:

Scott, Lesley

Publication type:

Journal Article

Recent Progress for the Effective Prevention and Treatment of Recurrent Clostridium difficile Infection.

Published in:

Infectious Diseases: Research & Treatment, 2018, n. 11, p. 1, doi. 10.1177/1178633718758023

By:

Ramsay, Isobel;
Brown, Nicholas M.;
Enoch, David A.

Publication type:

Article

Safety and Efficacy of Fidaxomicin in Patients With Clostridium Difficile Infection.

Published in:

Clinical Medicine Insights: Therapeutics, 2013, n. 5, p. 75, doi. 10.4137/CMT.S7279

By:

Donnelley, Monica A.;
Duby, Jeremiah J.;
Cocanour, Christine S.

Publication type:

Article

Use of fidaxomicin through a nasogastric tube for the treatment of septic shock caused by Clostridium difficile infection in a patient with oral cancer admitted to the Surgical Critical Care Unit.

Published in:

2013

By:

Maseda, Emilio;
Hernandez-Gancedo, Carmen;
Lopez-Tofiño, Araceli;
Suarez-de-la Rica, Alejandro;
Garcia-Bujalance, Silvia;
Gilsanz, Fernando

Publication type:

Letter

Prescribing Trends for Oral Vancomycin and Fidaxomicin after Guideline and Formulary Changes in Ontario, Canada: An Interrupted Time-Series Analysis.

Published in:

Canadian Journal of Hospital Pharmacy / Journal Canadien de la Pharmacie Hospitalière, 2024, v. 77, n. 3, p. 1, doi. 10.4212/cjhp.3560

By:

Maximos, Mira;
Maxwell, Colleen;
Gamble, John-Michael

Publication type:

Article

Fidaxomicin - the new drug for Clostridium difficile infection.

Published in:

Indian Journal of Medical Research, 2015, v. 141, n. 4, p. 398, doi. 10.4103/0971-5916.159251

By:

Vaishnavi, Chetana

Publication type:

Article

Fidaxomicin versus Vancomycin as a First-Line Treatment for Clostridium difficile-Associated Diarrhea in Specific Patient Populations: A Pharmacoeconomic Evaluation.

Published in:

Pharmacotherapy, 2017, v. 37, n. 12, p. 1489, doi. 10.1002/phar.2049

By:

Reveles, Kelly R.;
Backo, Jennifer L.;
Corvino, Frank A.;
Zivkovic, Marko;
Broderick, Kelly C.

Publication type:

Article

Characterization of a clinical Clostridioides difficile isolate with markedly reduced fidaxomicin susceptibility and a V1143D mutation in rpoB.

Published in:

2019

By:

Schwanbeck, Julian;
Riedel, Thomas;
Laukien, Friederike;
Schober, Isabel;
Oehmig, Ines;
Zimmermann, Ortrud;
Overmann, Jörg;
Groß, Uwe;
Zautner, Andreas E;
Bohne, Wolfgang

Publication type:

journal article

Pharmacokinetics and safety of fidaxomicin in patients with inflammatory bowel disease and Clostridium difficile infection: an open-label Phase IIIb/IV study (PROFILE).

Published in:

2018

By:

Högenauer, Christoph;
Karas, Andreas;
Reinisch, Walter;
Mahida, Yashwant;
Stallmach, Andreas;
Marteau, Philippe;
Rydzewska, Grazyna;
Ivashkin, Vladimir;
Gargalianos-Kakolyris, Panagiotis;
Michon, Ingrid;
Tretter, Reiner;
Adomakoh, Nicholas;
Georgopali, Areti

Publication type:

journal article

Extended-pulsed fidaxomicin versus vancomycin for Clostridium difficile infection in patients aged ≥60 years (EXTEND): analysis of cost-effectiveness.

Published in:

2018

By:

Cornely, Oliver A;
Watt, Maureen;
McCrea, Charles;
Goldenberg, Simon D;
Nigris, Enrico De;
De Nigris, Enrico

Publication type:

journal article

Characterization of the impact of rpoB mutations on the in vitro and in vivo competitive fitness of Clostridium difficile and susceptibility to fidaxomicin.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2018, v. 73, n. 4, p. 973, doi. 10.1093/jac/dkx486

By:

Kuehne, Sarah A.;
Dempster, Andrew W.;
Collery, Mark M.;
Joshi, Nimitray;
Jowett, Jamie;
Kelly, Michelle L.;
Cave, Rory;
Longshaw, Chris M.;
Minton, Nigel P.

Publication type:

Article

Analysis of Clostridium difficile biofilms: imaging and antimicrobial treatment.

Published in:

2018

By:

James, Garth A.;
Chesnel, Laurent;
Boegli, Laura;
deLancey Pulcini, Elinor;
Fisher, Steve;
Stewart, Philip S.

Publication type:

journal article

Susceptibility of Clostridium difficile isolates from a Phase 2 clinical trial of cadazolid and vancomycin in C. difficile infection.

Published in:

2016

By:

Gerding, D. N.;
Hecht, D. W.;
Louie, T.;
Nord, C. E.;
Talbot, G. H.;
Cornely, O. A.;
Buitrago, M.;
Best, E.;
Sambol, S.;
Osmolski, J. R.;
Kracker, H.;
Locher, H. H.;
Charef, P.;
Wilcox, M.

Publication type:

journal article

In vitro activity of surotomycin against contemporary clinical isolates of toxigenic Clostridium difficile strains obtained in Spain.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2015, v. 70, n. 8, p. 2311, doi. 10.1093/jac/dkv092

By:

Reigadas, E.;
Alcalá, L.;
Marín, M.;
Pelaéz, T.;
Martin, A.;
Iglesias, C.;
Bouza, E.

Publication type:

Article

In vitro susceptibility of Clostridium difficile to SMT19969 and comparators, as well as the killing kinetics and post-antibiotic effects of SMT19969 and comparators against C. difficile.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2015, v. 70, n. 6, p. 1751, doi. 10.1093/jac/dkv006

By:

Corbett, D.;
Wise, A.;
Birchall, S.;
Warn, P.;
Baines, S. D.;
Crowther, G.;
Freeman, J.;
Chilton, C. H.;
Vernon, J.;
Wilcox, M. H.;
Vickers, R. J.

Publication type:

Article

SMT19969 for Clostridium difficile infection (CDI): in vivo efficacy compared with fidaxomicin and vancomycin in the hamster model of CDI.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2015, v. 70, n. 6, p. 1757, doi. 10.1093/jac/dkv005

By:

Sattar, Abdul;
Thommes, Pia;
Payne, Lloyd;
Warn, Peter;
Vickers, Richard J.

Publication type:

Article

Clinical efficacy of fidaxomicin compared with vancomycin and metronidazole in Clostridium difficile infections: a meta-analysis and indirect treatment comparison.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2014, v. 69, n. 11, p. 2892, doi. 10.1093/jac/dku261

By:

Cornely, Oliver A.;
Nathwani, Dilip;
Ivanescu, Cristina;
Odufowora-Sita, Olatunji;
Retsa, Peny;
Odeyemi, Isaac A. O.

Publication type:

Article

Cost-effectiveness analysis of fidaxomicin versus vancomycin in Clostridium difficile infection.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2014, v. 69, n. 11, p. 2901, doi. 10.1093/jac/dku257

By:

Nathwani, Dilip;
Cornely, Oliver A.;
Van Engen, Anke K.;
Odufowora-Sita, Olatunji;
Retsa, Peny;
Odeyemi, Isaac A. O.

Publication type:

Article

Successful treatment of simulated Clostridium difficile infection in a human gut model by fidaxomicin first line and after vancomycin or metronidazole failure.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2014, v. 69, n. 2, p. 451, doi. 10.1093/jac/dkt347

By:

Chilton, C. H.;
Crowther, G. S.;
Freeman, J.;
Todhunter, S. L.;
Nicholson, S.;
Longshaw, C. M.;
Wilcox, M. H.

Publication type:

Article

In vitro selection, via serial passage, of Clostridium difficile mutants with reduced susceptibility to fidaxomicin or vancomycin.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2014, v. 69, n. 1, p. 41, doi. 10.1093/jac/dkt302

By:

Leeds, Jennifer A.;
Sachdeva, Meena;
Mullin, Steve;
Barnes, S. Whitney;
Ruzin, Alexey

Publication type:

Article

Successful use of fidaxomicin in recurrent Clostridium difficile infection in a child.

Published in:

2013

By:

Smeltzer, Stephanie;
Hassoun, Ali

Publication type:

Letter

Antimicrobial activity of LFF571 and three treatment agents against Clostridium difficile isolates collected for a pan-European survey in 2008: clinical and therapeutic implications.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2013, v. 68, n. 6, p. 1305

By:

Debast, Sylvia B.;
Bauer, Martijn P.;
Sanders, Ingrid M. J. G.;
Wilcox, Mark H.;
Kuijper, Ed J.

Publication type:

Article

Fidaxomicin inhibits toxin production in Clostridium difficile.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2013, v. 68, n. 3, p. 515, doi. 10.1093/jac/dks450

By:

Babakhani, Farah;
Bouillaut, Laurent;
Sears, Pamela;
Sims, Carlee;
Gomez, Abraham;
Sonenshein, Abraham L.

Publication type:

Article

Increases in Anti-infective Drug Prices, Subsequent Prescribing, and Outpatient Costs.

Published in:

JAMA Network Open, 2021, v. 4, n. 6, p. e2113963, doi. 10.1001/jamanetworkopen.2021.13963

By:

Lee, Junsoo;
Joo, Heesoo;
Maskery, Brian A.;
Alpern, Jonathan D.;
Park, Chanhyun;
Weinberg, Michelle;
Stauffer, William M.

Publication type:

Article

Australasian Society of Infectious Diseases updated guidelines for the management of Clostridioides difficile infection in adults and children in Australia and New Zealand.

Published in:

Internal Medicine Journal, 2025, v. 55, n. 3, p. 503, doi. 10.1111/imj.16638

By:

Longhitano, Anthony;
Roder, Christine;
Blackmore, Tim;
Campbell, Anita;
May, Meryta;
Athan, Eugene

Publication type:

Article

Novel Fidaxomicin Treatment Regimens for Patients With Multiple Clostridium difficile Infection Recurrences That Are Refractory to Standard Therapies.

Published in:

Open Forum Infectious Diseases, 2014, v. 1, n. 2, p. 1, doi. 10.1093/ofid/ofu069

By:

Soriano, Melinda M.;
Danziger, Larry H.;
Gerding, Dale N.;
Johnson, Stuart

Publication type:

Article

Proteomic Signatures of Clostridium difficile Stressed with Metronidazole, Vancomycin, or Fidaxomicin.

Published in:

Cells (2073-4409), 2018, v. 7, n. 11, p. 213, doi. 10.3390/cells7110213

By:

Maaß, Sandra;
Otto, Andreas;
Albrecht, Dirk;
Riedel, Katharina;
Trautwein-Schult, Anke;
Becher, Dörte

Publication type:

Article

Cost-effectiveness analysis of initial treatment strategies for mild-to-moderate Clostridium difficile infection in hospitalized patients.

Published in:

American Journal of Health-System Pharmacy, 2018, v. 75, n. 15, p. 1110, doi. 10.2146/ajhp170554

By:

Ford, Diana C.;
Schroeder, Mary C.;
Ince, Dilek;
Ernst, Erika J.

Publication type:

Article

Probable fidaxomicin-induced pancytopenia.

Published in:

American Journal of Health-System Pharmacy, 2018, v. 75, n. 8, p. 532, doi. 10.2146/ajhp170239

By:

Axtell, Samantha;
student, Aisha Shokoya Pharm.D.;
Yocum, Christine

Publication type:

Article

Derivation and validation of a simple clinical bedside score (ATLAS) for Clostridium difficile infection which predicts response to therapy.

Published in:

BMC Infectious Diseases, 2013, v. 13, n. 1, p. 1, doi. 10.1186/1471-2334-13-148

By:

Miller, Mark A.;
Louie, Thomas;
Mullane, Kathleen;
Weiss, Karl;
Lentnek, Arnold;
Golan, Yoav;
Kean, Yin;
Sears, Pam

Publication type:

Article

Fidaxomicin: A New Addition to the Clostridium difficile Armamentarium.

Published in:

Current Medical Literature: Gastroenterology, 2012, v. 31, n. 4, p. 95

By:

Bookstaver, P. Brandon;
James, Teldrin D.;
Siddiqui, Wajid;
Bland, Christopher M.;
Ahmed, Yasir;
Koch, Marla D.;
Quidley, April Miller

Publication type:

Article

Avoiding Premature Antibiotic Use in Recurrent Clostridioides difficile Infection After Fecal Microbiota Transplant.

Published in:

ACG Case Reports Journal, 2025, v. 12, n. 4, p. 1, doi. 10.14309/crj.0000000000001660

By:

Burdette, Rahim A.;
Whitt, Caroline C.;
Behm, Brian W.;
Warren, Cirle A.

Publication type:

Article

Emerging therapies for Clostridium difficile infection -- focus on fidaxomicin.

Published in:

Infection & Drug Resistance, 2013, v. 6, p. 41, doi. 10.2147/IDR.S24434

By:

Chaparro-Rojas, Fredy;
Mullane, Kathleen M.

Publication type:

Article

Diagnosis and Treatment of Clostridium difficile in Adults.

Published in:

JAMA: Journal of the American Medical Association, 2015, v. 313, n. 4, p. 398, doi. 10.1001/jama.2014.17103

By:

Bagdasarian, Natasha;
Rao, Krishna;
Malani, Preeti N.

Publication type:

Article

Erratum.

Published in:: 2019
Publication type:: Correction Notice

A Randomized, Placebo-controlled Trial of Fidaxomicin for Prophylaxis of Clostridium difficile–associated Diarrhea in Adults Undergoing Hematopoietic Stem Cell Transplantation.

Published in:

Clinical Infectious Diseases, 2019, v. 68, n. 2, p. 196, doi. 10.1093/cid/ciy484

By:

Mullane, Kathleen M;
Winston, Drew J;
Nooka, Ajay;
Morris, Michele I;
Stiff, Patrick;
Dugan, Michael J;
Holland, Henry;
Gregg, Kevin;
Adachi, Javier A;
Pergam, Steven A;
Alexander, Barbara D;
Dubberke, Erik R;
Broyde, Natalya;
Gorbach, Sherwood L;
Sears, Pamela S

Publication type:

Article

Reply to Fabre et al.

Published in:

Clinical Infectious Diseases, 2018, v. 67, n. 12, p. 1958, doi. 10.1093/cid/ciy475

By:

McDonald, L Clifford;
Johnson, Stuart;
Bakken, Johan S;
Garey, Kevin W;
Kelly, Ciaran;
Gerding, Dale N

Publication type:

Article

Building a Better Crystal Ball for Predicting Complications of Clostridium difficile Infection.

Published in:

2015

By:

Aronoff, David M.

Publication type:

Editorial

Risk Estimation for Recurrent Clostridium difficile Infection Based on Clinical Factors.

Published in:

Clinical Infectious Diseases, 2014, v. 58, n. 10, p. 1386, doi. 10.1093/cid/ciu107

By:

D'Agostino, Ralph B.;
Collins, Sylva H.;
Pencina, Karol M.;
Kean, Yin;
Gorbach, Sherwood

Publication type:

Article

An Economic Analysis: Is Fidaxomicin Worth the Cost?

Published in:

2014

By:

Shah, Hemal;
Doyle, Joseph J.;
Belletti, Daniel A.

Publication type:

Letter to the Editor

Hypersensitivity Reactions Associated With Fidaxomicin Use.

Published in:

Clinical Infectious Diseases, 2014, v. 58, n. 4, p. 537, doi. 10.1093/cid/cit719

By:

Iarikov, Dmitri E.;
Alexander, John;
Nambiar, Sumathi

Publication type:

Article

Is Fidaxomicin Worth the Cost? The Verdict Is Still Out!

Published in:

2014

By:

Hartzema, Abraham G.;
Chen, Chao

Publication type:

Letter to the Editor

Reply to Simon, Shah et al, and Hartzema and Chen.

Published in:

2014

By:

Bartsch, Sarah M.;
Umscheid, Craig A.;
Fishman, Neil;
Lee, Bruce Y.

Publication type:

Letter to the Editor